Nasal Spray Container Determination Should Precede Clinical Testing – FDA
This article was originally published in The Tan Sheet
Executive Summary
Container closure systems for nasal spray and inhalant drugs should be tested and found appropriate for use with a particular drug compound prior to conducting clinical and stability tests, an FDA guidance states